[p53 gene mutation in cancer of the colon and rectum]

Rev Med Chil. 2000 Sep;128(9):996-1004.
[Article in Spanish]

Abstract

Background: Genetic events associated to colorectal carcinoma are well characterized, but there is scanty information about this issue in Chilean subjects.

Aim: To determine the frequency and distribution of exons 5, 6, 7, 8 and 9 mutations and the immunohistochemical expression of p53 gene in biopsy samples of colorectal carcinoma.

Material and methods: p53 gene exons 5, 6, 7, 8 and 9 were directly sequenced in 42 biopsy samples of colorectal carcinoma. Immunohistochemical expression of p53 was determined in 35 samples.

Results: Thirty one discrete mutations (12 transitions, 11 transversions and 8 insertions) were observed in 21 samples (60%). Nine samples had mutations in exon 5, twelve samples had mutations in exon 6, seven samples had mutations in exon 7 and three samples had mutations in exons 8 and 9. Immunohistochemical expression of p53 protein was observed in 18 of 35 cases. There was a high correlation between the genetic alteration and immunohistochemistry, when p53 was expressed in more the 20% of cells. The positive and negative predictive values of p53 expression were 87 and 80% respectively. There was a non significant lower mortality among patients with mutations in their biopsies.

Conclusions: These results confirm the involvement of p53 gene mutations in colonic carcinogenesis. Immunohistochemical methods for the detection of p53 protein have a high predictive value.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adult
  • Colonic Neoplasms / genetics*
  • Exons / genetics
  • Female
  • Gene Frequency
  • Genes, p53 / genetics*
  • Humans
  • Male
  • Mutation / genetics*
  • Polymerase Chain Reaction
  • Predictive Value of Tests
  • Rectal Neoplasms / genetics*
  • Survival Analysis
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / isolation & purification*

Substances

  • Tumor Suppressor Protein p53